Caroline A. Nebhan
- Oncology top 2%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 10%
- Cancer Research top 10%
- Co-authors
- Douglas B. JohnsonJustin M. BalkoJavid J. MoslehiDonna J. WebbValentina PirazzoliWilliam PaoKaterina PolitiElisa de Stanchina
- Topics
- Cancer Immunotherapy and Biomarkers (10 papers)Melanoma and MAPK Pathways (6 papers)CAR-T cell therapy research (4 papers)
- Journals
- Journal of Biological ChemistryJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Caroline A. Nebhan
22 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.0k
- Molecular Biology 667
- Pulmonary and Respiratory Medicine 659
- Immunology 257
- Cancer Research 208
Countries citing papers authored by Caroline A. Nebhan
This map shows the geographic impact of Caroline A. Nebhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline A. Nebhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline A. Nebhan more than expected).
Fields of papers citing papers by Caroline A. Nebhan
This network shows the impact of papers produced by Caroline A. Nebhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline A. Nebhan. The network helps show where Caroline A. Nebhan may publish in the future.
Co-authorship network of co-authors of Caroline A. Nebhan
This figure shows the co-authorship network connecting the top 25 collaborators of Caroline A. Nebhan. A scholar is included among the top collaborators of Caroline A. Nebhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline A. Nebhan. Caroline A. Nebhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 11 | |
| 3 | 7 | |
| 4 | Immune-checkpoint inhibitors: long-term implications of toxicitybreakdown → | 610 |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 28 | |
| 9 | 28 | |
| 10 | 41 | |
| 11 | 6 | |
| 12 | 22 | |
| 13 | 9 | |
| 14 | 21 | |
| 15 | 22 | |
| 16 | 56 | |
| 17 | HER2 Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in EGFR -Mutant Lung Cancers That Lack the Second-Site EGFR T790M Mutationbreakdown → | 555 |
| 18 | 44 | |
| 19 | 35 | |
| 20 | 186 |
About Caroline A. Nebhan
Caroline A. Nebhan is a scholar working on Oncology, Developmental Neuroscience and Geriatrics and Gerontology, having authored 23 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Melanoma and MAPK Pathways (6 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Oncology (1.0k citations), Pulmonary and Respiratory Medicine (659 citations) and Cancer Research (208 citations). Caroline A. Nebhan has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Douglas B. Johnson, Justin M. Balko, Javid J. Moslehi, Donna J. Webb, Valentina Pirazzoli, William Pao, Katerina Politi, Elisa de Stanchina, Vincent A. Miller and Xiaoling Song. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.